Thus, for example, the simultaneous methylation analysis of SEPT9 and SDC2 (ColoDefense® test) in stool samples was able to obtain a sensitivity of 66.7% for advanced adenoma (AA) and 92.3% for CRC, with a specificity of 93.2% [158]. The gene discussed is SEPTIN9; the disease is colorectal carcinoma.